| Hans-Günter Meyer-Thompson | Buprenorphin
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market.
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market.
Randhawa PA, Brar R, Nolan S.
CMAJ. 2020 Jan 20;192(3):E73. doi: 10.1503/cmaj.74018. PMID: 31959660; PMCID: PMC6970598.